QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading symbol(s) |
Name of each exchange on which registered | ||
☒ |
Accelerated filer |
☐ | ||||
Non-accelerated filer |
☐ |
Smaller reporting company |
| |||
Emerging growth company |
|
PART I. |
||||||
ITEM 1. |
3 |
|||||
Consolidated Financial Statements (Unaudited): |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
9 |
||||||
ITEM 2. |
47 |
|||||
ITEM 3. |
75 |
|||||
ITEM 4. |
78 |
|||||
PART II. |
||||||
ITEM 1. |
79 |
|||||
ITEM 1A. |
79 |
|||||
ITEM 2. |
79 |
|||||
ITEM 3. |
79 |
|||||
ITEM 4. |
79 |
|||||
ITEM 5. |
79 |
|||||
ITEM 6. |
80 |
|||||
81 |
March 31, |
December 31, |
|||||||
2021 |
2020 |
|||||||
Assets |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Loans receivable |
||||||||
Current expected credit loss reserve |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Loans receivable, net |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total Assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and Equity |
||||||||
Secured debt agreements, net |
$ | $ | ||||||
Securitized debt obligations, net |
||||||||
Asset-specific debt agreements, net |
||||||||
Secured term loans, net |
||||||||
Convertible notes, net |
||||||||
Other liabilities |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies |
||||||||
Equity |
||||||||
Class A common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income (loss) |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Blackstone Mortgage Trust, Inc. stockholders’ equity |
||||||||
Non-controlling interests |
||||||||
|
|
|
|
|||||
Total Equity |
||||||||
|
|
|
|
|||||
Total Liabilities and Equity |
$ | $ | ||||||
|
|
|
|
Three Months Ended |
||||||||
March 31, |
||||||||
2021 |
2020 |
|||||||
Income from loans and other investments |
||||||||
Interest and related income |
$ | $ | ||||||
Less: Interest and related expenses |
||||||||
|
|
|
|
|||||
Income from loans and other investments, net |
||||||||
Other expenses |
||||||||
Management and incentive fees |
||||||||
General and administrative expenses |
||||||||
|
|
|
|
|||||
Total other expenses |
||||||||
Decrease (increase) in current expected credit loss reserve |
( |
) | ||||||
|
|
|
|
|||||
Income (loss) before income taxes |
( |
) | ||||||
Income tax provision |
||||||||
|
|
|
|
|||||
Net income (loss) |
( |
) | ||||||
|
|
|
|
|||||
Net income attributable to non-controlling interests |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net income (loss) attributable to Blackstone Mortgage Trust, Inc. |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Net income (loss) per share of common stock basic and diluted |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Weighted-average shares of common stock outstanding, basic and diluted |
||||||||
|
|
|
|
Three Months Ended |
||||||||
March 31, |
||||||||
2021 |
2020 |
|||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Other comprehensive income |
||||||||
Unrealized loss on foreign currency translation |
( |
) | ( |
) | ||||
Realized and unrealized gain on derivative financial instruments |
||||||||
|
|
|
|
|||||
Other comprehensive income |
||||||||
|
|
|
|
|||||
Comprehensive income (loss) |
( |
) | ||||||
Comprehensive income attributable to non-controlling interests |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Comprehensive income (loss) attributable to Blackstone Mortgage Trust, Inc. |
$ | $ | ( |
) | ||||
|
|
|
|
Blackstone Mortgage Trust, Inc. |
||||||||||||||||||||||||||||
Class A Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Stockholders’ Equity |
Non-controlling Interests |
Total Equity |
||||||||||||||||||||||
Balance at December 31, 2019 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | |||||||||||||||||
Adoption of ASU 2016-13, see Note 2 |
— | — | — | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||
Shares of class A common stock issued, net |
— | — | — | — | ||||||||||||||||||||||||
Restricted class A common stock earned |
— | — | — | — | ||||||||||||||||||||||||
Dividends reinvested |
— | — | ( |
) | — | |||||||||||||||||||||||
Deferred directors’ compensation |
— | — | — | — | ||||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | ||||||||||||||||||||||||
Net (loss) income |
— | — | — | ( |
) | ( |
) | ( |
) | |||||||||||||||||||
Dividends declared on common stock, $ |
— | — | — | ( |
) | ( |
) | — | ( |
) | ||||||||||||||||||
Contributions from non-controlling interests |
— | — | — | — | — | |||||||||||||||||||||||
Distributions to non-controlling interests |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at March 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||
Shares of class A common stock issued, net |
— | — | — | — | ||||||||||||||||||||||||
Restricted class A common stock earned |
— | — | — | — | ||||||||||||||||||||||||
Dividends reinvested |
— | — | ( |
) | — | |||||||||||||||||||||||
Deferred directors’ compensation |
— | — | — | — | ||||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | ||||||||||||||||||||||||
Net income |
— | — | — | |||||||||||||||||||||||||
Dividends declared on common stock, $ |
— | — | — | ( |
) | ( |
) | — | ( |
) | ||||||||||||||||||
Contributions from non-controlling interests |
— | — | — | — | — | |||||||||||||||||||||||
Distributions to non-controlling interests |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at March 31, 2021 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||||
2021 |
2020 |
|||||||||
Cash flows from operating activities |
||||||||||
Net income (loss) |
|
|
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities |
|
|
||||||||
Non-cash compensation expense |
|
|
||||||||
Amortization of deferred fees on loans and debt securities |
|
|
( |
) | ( |
) | ||||
Amortization of deferred financing costs and premiums/ discount on debt obligations |
|
|||||||||
(Decrease) increase in current expected credit loss reserve |
|
|
( |
) | ||||||
Unrealized gain on assets denominated in foreign currencies, net |
|
|
( |
) | ( |
) | ||||
Unrealized loss on derivative financial instruments, net |
|
|
||||||||
Realized loss on derivative financial instruments, net |
|
|
||||||||
Changes in assets and liabilities, net |
|
|
||||||||
Other assets |
|
|
( |
) | ( |
) | ||||
Other liabilities |
|
|
||||||||
|
|
|
|
|
|
|||||
Net cash provided by operating activities |
|
|
||||||||
|
|
|
|
|
|
|||||
Cash flows from investing activities |
|
|
||||||||
Origination and fundings of loans receivable |
|
|
( |
) | ( |
) | ||||
Principal collections and sales proceeds from loans receivable and debt securities |
|
|
||||||||
Origination and exit fees received on loans receivable |
|
|
||||||||
Receipts under derivative financial instruments |
|
|
||||||||
Payments under derivative financial instruments |
|
|
( |
) | ( |
) | ||||
Collateral deposited under derivative agreements |
|
|
( |
) | ( |
) | ||||
Return of collateral deposited under derivative agreements |
|
|
||||||||
|
|
|
|
|
|
|||||
Net cash used in investing activities |
|
|
( |
) | ( |
) | ||||
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||
2021 |
2020 |
|||||||
Cash flows from financing activities |
||||||||
Borrowings under secured debt agreements |
$ | $ | ||||||
Repayments under secured debt agreements |
( |
) | ( |
) | ||||
Proceeds from issuance of collateralized loan obligations |
||||||||
Repayment of collateralized loan obligations |
( |
) | ( |
) | ||||
Borrowings under asset-specific debt agreements |
||||||||
Repayments under asset-specific debt agreements |
( |
) | ||||||
Net proceeds from issuance of secured term loan |
||||||||
Repayments of secured term loan |
( |
) | ( |
) | ||||
Payment of deferred financing costs |
( |
) | ( |
) | ||||
Contributions from non-controlling interests |
||||||||
Distributions to non-controlling interests |
( |
) | ( |
) | ||||
Dividends paid on class A common stock |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net (decrease) increase in cash and cash equivalents |
( |
) | ||||||
Cash and cash equivalents at beginning of period |
||||||||
Effects of currency translation on cash and cash equivalents |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | $ | ||||||
|
|
|
|
|||||
Supplemental disclosure of cash flows information |
||||||||
Payments of interest |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Receipts (payments) of income taxes |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Supplemental disclosure of non-cash investing and financing activities |
|
|||||||
Dividends declared, not paid |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Loan principal payments held by servicer, net |
$ | $ | ||||||
|
|
|
|
• | U.S. Loans |
• | Non-U.S. Loans |
• | Unique Loans |
• | Impaired Loans non-recoverability may also be concluded if, in our determination, it is nearly certain that all amounts due will not be collected. |
Impact of ASU 2016-13 Adoption |
||||
Assets: |
||||
Loans |
||||
U.S. Loans |
$ | |||
Non-U.S. Loans |
||||
Unique Loans |
||||
|
|
|||
CECL reserve on loans |
$ | |||
|
|
|||
CECL reserve on held-to-maturity |
||||
Liabilities: |
||||
CECL reserve on unfunded loan commitments |
||||
|
|
|||
Total impact of ASU 2016-13 adoption on retained earnings |
$ | |||
|
|
1 - |
Very Low Risk | |||
2 - |
Low Risk | |||
3 - |
Medium Risk | |||
4 - |
High Risk/Potential for Loss: | |||
5 - |
Impaired/Loss Likely: |
• | Level 1: Generally includes only unadjusted quoted prices that are available in active markets for identical financial instruments as of the reporting date. |
• | Level 2: Pricing inputs include quoted prices in active markets for similar instruments, quoted prices in less active or inactive markets for identical or similar instruments where multiple price quotes can be obtained, and other observable inputs, such as interest rates, yield curves, credit risks, and default rates. |
• | Level 3: Pricing inputs are unobservable for the financial instruments and include situations where there is little, if any, market activity for the financial instrument. These inputs require significant judgment or estimation by management of third-parties when determining fair value and generally represent anything that does not meet the criteria of Levels 1 and 2. |
• | Cash and cash equivalents: The carrying amount of cash and cash equivalents approximates fair value. |
• | Loans receivable, net: The fair values of these loans were estimated by our Manager based on a discounted cash flow methodology, taking into consideration various factors including capitalization rates, discount rates, leasing, credit worthiness of major tenants, occupancy rates, availability and cost of financing, exit plan, loan sponsorship, actions of other lenders, and other factors deemed relevant by our Manager. |
• | Debt securities held-to-maturity: |
• | Derivative financial instruments: The fair value of our foreign currency and interest rate contracts was estimated using advice from a third-party derivative specialist, based on contractual cash flows and observable inputs comprising foreign currency rates and credit spreads. |
• | Secured debt agreements, net: The fair value of these instruments was estimated based on the rate at which a similar credit facility would currently be priced. |
• | Securitized debt obligations, net: The fair value of these instruments was estimated by utilizing third-party pricing service providers. In determining the value of a particular investment, pricing service providers may use broker-dealer quotations, reported trades, or valuation estimates from their internal pricing models to determine the reported price. |
• | Asset-specific debt agreements, net: The fair value of these instruments was estimated based on the rate at which a similar agreement would currently be priced. |
• | Secured term loans, net: The fair value of these instruments was estimated by utilizing third-party pricing service providers. In determining the value of a particular investment, pricing service providers may use broker-dealer quotations, reported trades, or valuation estimates from their internal pricing models to determine the reported price. |
• | Convertible notes, net: Each series of the convertible notes is actively traded and their fair values were obtained using quoted market prices. |
March 31, 2021 |
December 31, 2020 |
|||||||
Number of loans |
||||||||
Principal balance |
$ | $ | ||||||
Net book value |
$ | $ | ||||||
Unfunded loan commitments (1) |
$ | $ | ||||||
Weighted-average cash coupon (2) |
% | % | ||||||
Weighted-average all-in yield(2) |
% | % | ||||||
Weighted-average maximum maturity (years) (3) |
____________ __ _ _ |
(1) |
Unfunded commitments will primarily be funded to finance our borrowers’ construction or development of real estate-related assets, capital improvements of existing assets, or lease-related expenditures. These commitments will generally be funded over the term of each loan, subject in certain cases to an expiration date. | |||||
(2) |
The weighted-average cash coupon and all-in yield are expressed as a spread over the relevant floating benchmark rates, which include USD LIBOR, GBP LIBOR, EURIBOR, STIBOR, BBSY, and CDOR, as applicable to each loan. As of March 31, 2021, all-in yield includes the amortization of deferred origination and extension fees, loan origination costs, and purchase discounts, as well as the accrual of exit fees. Excludes loans accounted for under the cost-recovery method. | |||||
(3) |
Maximum maturity assumes all extension options are exercised by the borrower, however our loans may be repaid prior to such date. As of March 31, 2021, |
Principal Balance |
Deferred Fees / Other Items (1) |
Net Book Value |
||||||||||
Loans receivable, as of December 31, 2020 |
$ | $ | ( |
) | $ | |||||||
Loan fundings |
— | |||||||||||
Loan repayments and sales |
( |
) | — | ( |
) | |||||||
Unrealized (loss) gain on foreign currency translation |
( |
) | ( |
) | ||||||||
Deferred fees and other items |
— | ( |
) | ( |
) | |||||||
Amortization of fees and other items |
— | |||||||||||
Loans receivable, as of March 31, 2021 |
$ | $ | ( |
) | $ | |||||||
CECL reserve |
( |
) | ||||||||||
Loans receivable, net, as of March 31, 2021 |
$ | |||||||||||
____________ __ _ _ |
(1) |
Other items primarily consist of purchase and sale discounts or premiums, exit fees, and deferred origination expenses. |
March 31, 2021 |
||||||||||||||||
Property Type |
Number of Loans |
Net Book Value |
Total Loan Exposure (1)(2) |
Percentage of Portfolio |
||||||||||||
Office |
|
$ | $ | |
||||||||||||
Hospitality |
|
|
||||||||||||||
Multifamily |
|
|
||||||||||||||
Industrial |
|
|
||||||||||||||
Retail |
|
|
||||||||||||||
Life Sciences |
|
|
||||||||||||||
Self-Storage |
|
|
||||||||||||||
Condominium |
|
|
||||||||||||||
Other |
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total loans receivable |
$ |
$ |
||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
CECL reserve |
( |
) | ||||||||||||||
|
|
|||||||||||||||
Loans receivable, net |
$ | |||||||||||||||
|
|
|||||||||||||||
Geographic Location |
Number of Loans |
Net Book Value |
Total Loan Exposure (1)(2) |
Percentage of Portfolio |
||||||||||||
United States |
||||||||||||||||
Northeast |
|
$ | $ | |
||||||||||||
West |
|
|
||||||||||||||
Southeast |
|
|
||||||||||||||
Midwest |
|
|
||||||||||||||
Southwest |
|
|
||||||||||||||
Northwest |
|
— | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
|
|
||||||||||||||
International |
||||||||||||||||
United Kingdom |
|
|
||||||||||||||
Ireland |
|
|
||||||||||||||
Spain |
|
|
||||||||||||||
Australia |
|
|
||||||||||||||
Canada |
|
— | ||||||||||||||
Other Europe |
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
|